QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 6,080.00
-20.00 (-0.33%)
At close: Aug 11, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 69.81 billion as of August 11, 2026.
Market Cap
69.81B
Enterprise Value
52.90B
Revenue
9.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,080.00
ChartMarket Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 69.81B, a decrease of -65.09%. That is a compound annual growth rate of -79.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 69.81B | -60.52% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 80.23B |
| EyeGene | 78.81B |
| CTCBIO | 78.42B |
| ABION | 75.78B |
| BIO-FD&C | 72.17B |
| IMGT Co.,Ltd. | 68.33B |
| PanGen Biotech | 67.84B |
| AriBioLab | 65.13B |